Search Results

New research suggests a small group of pediatric brain tumor patients may benefit from immunotherapy.

SARS-CoV-2 may dramatically impair the immune response by reprogramming neutrophils resulting in severe covid.

Researchers develop antibody therapy to target cancer by focusing on the tumour environment, showing promise for wider cancer treatment applications

Afami-cel Phase I trial shows noteworthy responses in synovial sarcoma

Study finds blocking a key protein may boost CAR T-cell activity and improve outcomes in blood cancer treatment.

Hope for patients: Academic CAR‑T therapies make cancer treatment faster and more affordable.